hrp0098p1-266 | Growth and Syndromes 4 | ESPE2024

AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies.

Hatziagapiou Kyriaki , Georgakopoulou Danai , Polytarchou Anastasia , Moudaki Aggeliki , Kanaka-Gantenbein Christina , D Sakka Sophia

Background: Achondroplasia (ACH) is an autosomal dominant condition, resulting from pathogenic missense FGFR3 (fibroblast-growth-factor receptor-3) variants. Foramen magnum stenosis (FMS) is a severe complication, with infants and younger children being at higher risk. FMS may be asymptomatic or cause cervical-medullary compression (CMC), presenting with hydrocephalus, hypotonia or hypertonia, central sleep apnea and sudden death. The scope of the stu...

hrp0082p3-d2-992 | Thyroid (1) | ESPE2014

Thyroid Pathology Among 14-Year-Old Adolescents

Statova Anastasia

Background: Thyroid diseases rank first in endocrine pathology among children with the iodine deficiency disorder (IDD) being the significant part.Objective and hypotheses: To study the frequency of thyroid pathology in view of the results of the profound preventive medical check-up of 14-year-old teenagers of Krasnodar.Method: We examined 578 adolescents (301 boys and 277 girls). All adolescents were examined by an endocrinologist...

hrp0097p1-526 | Growth and Syndromes | ESPE2023

The first description of neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome)in the Russian Federation.

Kungurtseva Anastasiia , Tikhonovich Yulia , Popovich Anastasiia , Vitebskaya Alisa

Introduction: Wiedemann-Rautenstrauch syndrome (WRS). or neonatal progeroid syndrome, is an orphan hereditary disease associated predominantly with bi-allelic mutations in the POLR3A, POLR3B, and POLR3GL genes and characterized by congenital lipodystrophy, progeroid facial features, and premature aging. Unlike Hutchinson-Gilford progeria, the clinical features of the syndrome are evident at birth. The prevalence of the disease is unknown; 19 proven clinical ca...

hrp0097p2-241 | Late Breaking | ESPE2023

Primary hyperparathyroidism in children

Benina Anastasia , Kolodkina Anna , Bezlepkina Olga

Key words: primary hyperparathyroidism, parathyroid gland, genetic study.Background: Primary hyperparathyroidism (PHPT) is a rare disease with a prevalence up to 2-5:100,000. About 90-95% of cases are isolated adenomas, 5-10% cases are due to hereditary syndromes. Parathyroid carcinomas occur in less than 1%.Aim: To study clinical features and genetic characteristics of patients wi...

hrp0098p2-49 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

A case of parathyroid carcinoma in a pediatric patient.

Benina Anastasia , Kolodkina Anna , Bezlepkina Olga

Introduction: Parathyroid carcinoma (PC) is a malignant neoplasm and occurs in patients with primary hyperparathyroidism (PHPT) in less than 1% of cases. There are few descriptions of PC in children in the literature. Clinical manifestations of PHPT in children are highly variable: the disease may present with dyspeptic manifestations, symptoms of intoxication, bone deformities, urolithiasis, cholelithiasis or be asymptomatic.Mat...

hrp0098p3-76 | Diabetes and Insulin | ESPE2024

The awareness of teachers and medical school workers regarding diabetes in children

Furdela Viktoriya , Pavlyshyn Halyna , Furdela Anastasiia

Introdaction: The prevalence of Diabetes type 1 constantly increases worldwide from birth to 12 years with a peak in school age. The appearance of students with diabetes in class may be a challenge for their teachers. Diabetic children spend routinely most of their daytime at school and may need adult support in insulin injections or at episodes of hypo and hyperglycemia during school activities and meals. Therefore, our study aims to evaluate the knowledge an...

hrp0092p2-132 | Fat, Metabolism and Obesity | ESPE2019

Association Between TSH and Metabolic Syndrome in Obese Children and Adolescents

Guzzetti Chiara , Ibba Anastasia , Casula Letizia , Casano Simona , Loche Sandro

Introduction: Hyperthyrotropinemia is common in patients with obesity and has been hypothesized that high TSH could be associated with an adverse metabolic profile. Few studies have been performed in pediatric population and the results are controversial.Objective: Aim of the study was to evaluate the association between TSH and metabolic syndrome (MS) in a large group of obese children and adolescents.<p class="abst...

hrp0089p1-p044 | Diabetes &amp; Insulin P1 | ESPE2018

Parental Anxiety about Hypoglycemia of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) and the Associated Factors

Ntinou Evangelia , Barbouni Anastasia , Liveri Athanasia , Karavanaki Kyriaki

Introduction: The anxiety for hypoglycemia is a major stress factor for parents of children with T1DM and has been associated with poor diabetic control, reduced insulin doses and school-age children.Purpose: To determine the frequency and severity of parental anxiety for hypoglycemia and the associated factors.Patients and methods: The study included parents [21 (23.9%) fathers and 67 (76.1%) mothers] of 88 T1DM patients, with a m...

hrp0089p2-p140 | Fat, Metabolism and Obesity P2 | ESPE2018

Sex-related Differences and Effect of Puberty on Metabolic Syndrome in Obese Children and Adolescents

Guzzetti Chiara , Ibba Anastasia , Casula Letizia , Pilia Sabrina , Loche Sandro

Introduction: Metabolic syndrome (MS) is a known complication of obesity. It is still unclear whether gender and puberty influence the prevalence of MS in children and adolescents.Objective: Aim of the study was to evaluate the effect of gender and puberty on the prevalence of MS and on cardiovascular risk factors (CVRF) in obese children and adolescents.Patients and Methods: 1437 obese patients (age 9.7 (2.2–17.9) ys; 660 Mal...

hrp0082p2-d2-298 | Bone (1) | ESPE2014

Zoledronic Acid for Management of Osteopenia of Prematurity and Associated Ventilator Dependency

White Mary , Pellicano Anastasia , Zacharin Margaret , Simm Peter

Background: The effect of bisphosphonates in patients with severe osteopenia of prematurity is unknown in terms of either fracture prevention or long-term safety. A 6-month-old male infant born at 24+2 weeks gestation was referred for consideration of bisphosphonate therapy in the management of severe osteopenia of prematurity. The neonatal course included chronic lung disease requiring four courses of corticosteroids. Despite optimal calcium, phosphate and vitamin D supplemen...